Artigo Revisado por pares

Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study

2024; Elsevier BV; Volume: 25; Issue: 6 Linguagem: Inglês

10.1016/s1470-2045(24)00141-4

ISSN

1474-5488

Autores

Milena Sant, Claudia Vener, Roberto Lillini, Silvia Rossi, S. Bonfarnuzzo, Rafael Marcos‐Gragera, Marc Maynadié, Kaire Innos, Keiu Paapsi, Otto Visser, Alice Bernasconi, Elena Demuru, Corrado Di Benedetto, Seyed Mohsen Mousavi, Marcel Blum, Philip Went, Diego Serraino, Damien Bennett, María‐José Sánchez, Roberta De Angelis, Monika Hackl, E. Van Eycken, Nancy Van Damme, Z. Valerianova, Mario Šekerija, Vasos Scoutellas, Anna Demetriou, Ladislav Dušek, Denisa Krejici, Hans H. Storm, Margit Mägi, Kaire Innos, Janne Pitkäniemi, Michel Velten, Xavier Troussard, Anne‐Marie Bouvier, Valérie Jooste, Anne‐Valérie Guizard, Guy Launoy, Sandrine Dabakuyo Yonli, Marc Maynadié, Anne‐Sophie Woronoff, Jean‐Baptiste Nousbaum, Gaëlle Coureau, Alain Monnereau, Isabelle Baldi, Karima Hammas, Brigitte Trétarre, Marc Colonna, Sandrine Plouvier, Tania d’Almeida, F. Molinié, Anne Cowppli‐Bony, Simona Bara, Adeline Debreuve, Gautier Défossez, B. Lapôtre‐Ledoux, Pascale Grosclaude, Laëtitia Daubisse‐Marliac, Sabine Luttmann, Andrea Eberle, Roland Stabenow, Alice Nennecke, Joachim Kieschke, Sylke Ruth Zeißig, Bernd Holleczek, Alexander Katalinic, Helgi Birgisson, Deirdre M. Murray, Paul Walsh, Guido Mazzoleni, Fabio Vittadello, Francesco Cuccaro, Rocco Galasso, Giuseppe Sampietro, Stefano Rosso, Cinzia Gasparotti, Giovanni Maifredi, Margherita Ferrante, Rosalia Ragusa, Antonella Sutera Sardo, Maria Letizia Gambino, Monica Lanzoni, Paola Ballotari, Erica Giacomazzi, Stefano Ferretti, Adele Caldarella, Gianfranco Manneschi, Gemma Gatta, Milena Sant, Paolo Baili, Franco Berrino, Laura Botta, Annalisa Trama, Roberto Lillini, Alice Bernasconi, S. Bonfarnuzzo, Claudia Vener, Fabio Didonè, Paolo Lasalvia, Lucia Buratti, Giovanna Tagliabue, Diego Serraino, Luigino Dal Maso, Riccardo Capocaccia, Roberta De Angelis, Elena Demuru, Francesco Cerza, Fabrizio Di Mari, Corrado Di Benedetto, Silvia Rossi, Mariano Santaquilani, Serenella Venanzi, Marco Tallon, Luca Boni, Silvia Iacovacci, Valerio Gennaro, Antonio Russo, Federico Gervasi, Gianbattista Spagnoli, Luca Cavalieri d’Oro, Mario Fusco, Maria Francesca Vitale, M. Usala, Walter Mazzucco, Maria Michiara, Giorgio Chiranda, Giuseppe Cascone, Concetta Patrizia Rollo, Lucìa Mangone, Fabio Falcini, Rossella Cavallo, Daniela Piras, A Madeddu, Francesca Bella, Anna Clara Fanetti, Sante Minerba, Giuseppina Candela, T. Scuderi, Roberto Vito Rizzello, Fabrizio Stracci, Massimo Rugge, Angelita Brustolin, Santa Pildava, Giedrė Smailytė, Miriam Azzopardi, Tom Børge Johannesen, Joanna Didkowska, Urszula Wojciechowska, Magdalena Bielska‐Lasota, Ana Pais, María José Bento, Ana Maia Ferreira, António Lourenço, C. Safaei Diba, Vesna Zadnik, Tina Žagar, Carmen Sánchez-Contador Escudero, P. Franch Sureda, Arantza López de Munain, Marta De-La-Cruz, María Dolores Rojas, Araceli Alemán, Ana Vizcaíno, Rafael Marcos‐Gragera, Arantza Sanvisens, María‐José Sánchez, María Dolores Chirlaque López, Antonia Sánchez-Gil, Marcela Guevara, Eva Ardanáz, Jaume Galcerán, Marià Carulla, Yvan Bergeron, Christine Bouchardy, Seyed Mohsen Mousavi, Philip Went, Marcel Blum, Andrea Bordoni, Otto Visser, Sarah Stevens, John Broggio, Damien Bennett, Anna Gavin, David Morrison, Dyfed Huws,

Tópico(s)

Lymphoma Diagnosis and Treatment

Resumo

Management of lymphoid malignancies requires substantial health system resources. Total national health expenditure might influence population-based lymphoid malignancy survival. We studied the long-term survival of patients with 12 lymphoid malignancy types and examined whether different levels of national health expenditure might explain differences in lymphoid malignancy prognosis between European countries and regions.

Referência(s)
Altmetric
PlumX